Increased arterial stiffness raises stroke risk in type 2 diabetes
Increased arterial stiffness raises stroke risk in type 2 diabetes
Adults with type 2 diabetes who also have stiffer arteries are more likely to experience stroke and vascular mortality than those without such arterial stiffness, according to findings presented in Diabetic Medicine. Source: Increased arterial stiffness raises stroke risk in type 2 Read more
Smoking With Diabetes: A Double Whammy
Smoking With Diabetes: A Double Whammy
While cigarette labels warn people about how smoking can cause cancer, researchers believe there are also consequences for diabetic patients. Source: Smoking With Diabetes: A Double Read more
Comparison of Human and Murine Enteroendocrine Cells by Transcriptomic and Peptidomic Profiling
Comparison of Human and Murine Enteroendocrine Cells by Transcriptomic and Peptidomic Profiling
Enteroendocrine cells (EECs) produce hormones such as glucagon-like peptide 1 and peptide YY that regulate food absorption, insulin secretion, and appetite. Based on the success of glucagon-like peptide 1–based therapies for type 2 diabetes and obesity, EECs are themselves the focus of drug discovery programs to enhance gut hormone secretion. The aim of this study... Read more Read more
Key to type 2 diabetes remission may be loss of half a gram of pancreas fat
Key to type 2 diabetes remission may be loss of half a gram of pancreas fat
Adults with type 2 diabetes may be able to achieve sustainable remission from the disease by losing weight and decreasing fat in the pancreas and liver, according to data presented at the Read more
Endocrine diseases ‘emerging epidemic’ after immune checkpoint inhibitor therapies
Endocrine diseases ‘emerging epidemic’ after immune checkpoint inhibitor therapies
Recently approved immune checkpoint inhibitor therapies are now increasingly used for a variety of cancers and other conditions, yet clinicians are only beginning to confront a range of endocrinopathies triggered by such treatments, including thyroid disease, pituitary disorders and insulin-dependent diabetes, according to a speaker here. Source: Endocrine diseases ‘emerging epidemic’ after immune checkpoint inhibitor... Read more Read more
Linagliptin Does Not Increase Adverse Renal Events in Patients With T2D, Kidney Disease
Linagliptin Does Not Increase Adverse Renal Events in Patients With T2D, Kidney Disease
Treatment with linagliptin in patients with type 2 diabetes and cardiovascular and/or kidney disease had no impact on risk for cardiovascular or kidney events. Source: Linagliptin Does Not Read more
A Practical Guide to Delivering Nutritional Advice to People with Diabetes
A Practical Guide to Delivering Nutritional Advice to People with Diabetes
  Dietary advice is fundamental to the management of diabetes. Although ideally such advice should be delivered by a state-registered dietitian, it is more usually delivered by other health professionals. The primary focus for those with type 1 diabetes is carbohydrate counting and insulin adjustment and for the majority of people with type 2 diabetes,... Read more Read more
Colchicine May Improve Obesity-Induced Inflammation
Colchicine May Improve Obesity-Induced Inflammation
Colchicine is safe and effective at improving obesity-associated inflammatory measures among adults with obesity and metabolic syndrome (MetS) without diabetes, according to a pilot study Read more
Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health
Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health
  Excess added sugars, particularly from sugar-sweetened beverages, are a major risk factor for cardiometabolic diseases including cardiovascular disease and type 2 diabetes mellitus. In 2016, the US Food and Drug Administration mandated the labeling of added sugar content on all packaged foods and beverages. Yet, the potential health impacts and cost-effectiveness of this policy... Read more Read more
Increased serum uric acid in adolescents predicts hypertension, diabetic kidney disease
Increased serum uric acid in adolescents predicts hypertension, diabetic kidney disease
More than 25% of teens with type 2 diabetes have hyperuricemia, which increases their risks for developing hypertension, cardiovascular disease and kidney disease, according to findings presented in Diabetes Care. Source: Increased serum uric acid in adolescents predicts hypertension, diabetic kidney Read more